<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To investigate the relationship between serum SIL-2R levels and <z:hpo ids='HP_0000554'>uveitis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: SIL-2R levels were measured in sera of 64 patients with active <z:hpo ids='HP_0000554'>uveitis</z:hpo> by ELISA assay, 61 healthy subjects as control </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Serum SIL-2R levels in the patients with active <z:hpo ids='HP_0000554'>uveitis</z:hpo> were significantly higher than that in the controls, but there were no significant difference among <z:hpo ids='HP_0012122'>anterior uveitis</z:hpo>, <z:hpo ids='HP_0012124'>intermediate uveitis</z:hpo>, <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet disease</z:e> and <z:e sem="disease" ids="C0042170" disease_type="Disease or Syndrome" abbrv="">Vogt-Koyanagi-Harada syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>After therapy the serum SIL-2R levels were obviously decreased </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSION: SIL-2R Levels in serum correlate with activity of <z:hpo ids='HP_0000554'>uveitis</z:hpo> </plain></SENT>
</text></document>